Home  
  Our Team  
  Patient Info  
  Services  
   
  Pay My Bill  
  Contact Us  

News for Healthier Living

Phase 1 BAFF CAR T clinical trial for patients with relapsed and refractory multiple myeloma underway at UH Seidman Cancer Center

University Hospitals (UH) Seidman Cancer Center hematologist-oncologist Leland Metheny, MD, is leading the trial. He says in the two years since the foundational pre-clinical work was completed, the team has shown that it's feasible to manufacture BAFF CAR T-cells for human subjects.

August 15, 2024


December 29 2025

December 28 2025

December 27 2025

December 26 2025

December 24 2025

December 23 2025

December 22 2025

December 21 2025

December 20 2025

December 19 2025

December 18 2025

December 17 2025

December 16 2025